Related Experiment Videos
alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
D Van Gool1, B De Strooper, F Van Leuven
1Department of Neuropathology, University Hospital, Gasthuisberg, Leuven, Belgium.
Abstract:
Because it has been suggested that alpha 2M could be involved in the generation of amyloid peptide, attention was given to a possible association of alpha 2M expression and amyloid accumulation in the brain. Therefore, we investigated the presence of the proteinase inhibitor alpha 2-macroglobulin (alpha 2M) in the cerebra of 4 patients with Alzheimer's Disease (AD). One case of a patient with Down's syndrome, 2 cases of patients with Dementia of the Lewy Body type (DLB), 1 case of an aged, clinically nondemented person who displayed many amyloid plaques, and 3 normal aged control brains were also studied. The results obtained by immunocytochemistry with monoclonal antibodies directed against two different epitopes of human alpha 2M showed an association of alpha 2M, only with neuritic-type plaques in patients with AD. No alpha 2M immunoreactivity was found in either preamyloid-type plaques or burned out-type plaques in AD, DLB, or aged nondemented controls. The results do not support a direct role of this proteinase inhibitor in the formation of amyloid. Because alpha 2M is observed to be associated with reactive microglia in the outer border of the neuritic plaques, the data suggest that alpha 2M could be a marker for an inflammatory cellular process in these neuritic plaques.
Insights
Alpha 2-macroglobulin (alpha 2M) was investigated in Alzheimer's Disease (AD) brains. Alpha 2M was found in neuritic plaques, suggesting it may mark inflammation rather than amyloid formation.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Alpha 2-macroglobulin (alpha 2M) has been implicated in amyloid peptide generation.
- Understanding alpha 2M's role in neurodegenerative diseases is crucial.
Purpose of the Study:
- To investigate the association between alpha 2M expression and amyloid accumulation in Alzheimer's Disease (AD).
- To determine if alpha 2M is present in different types of amyloid plaques.
Main Methods:
- Immunocytochemistry using monoclonal antibodies against human alpha 2M.
- Analysis of brain tissue from AD patients, Down's syndrome, Dementia of the Lewy Body type (DLB), non-demented controls, and normal aged controls.
Main Results:
- Alpha 2M was exclusively associated with neuritic-type plaques in AD patients.
- No alpha 2M immunoreactivity was detected in preamyloid or burned-out plaques across all studied groups.
- Alpha 2M colocalized with reactive microglia at the periphery of neuritic plaques.
Conclusions:
- The findings do not support a direct role for alpha 2M in amyloid formation.
- Alpha 2M may serve as a marker for inflammatory processes within neuritic plaques in AD.